Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) ‐ outcomes and mutation profile from venetoclax resistant MCL patients
暂无分享，去创建一个
Michael L. Wang | C. Flowers | Shaojun Zhang | Guangchun Han | Linghua Wang | Jianhua Zhang | Xingzhi Song | P. Jain | R. Kanagal-Shamanna | L. Medeiros | Shaoying Li | C. Yin | Changying Jiang | K. Nomie | L. Fayad | J. Westin | S. Neelapu | S. Thirumurthi | S. Iyer | G. Tang | F. Vega | J. Romaguera | F. Samaniego | L. Nastoupil | N. Fowler | R. Nair | C. Ok | M. Badillo | J. Aranda | Holly A. Hill | Yixin Yao | Shuangtao Zhao | Guofan Xu | Wendy Chen | O. Oriabure | S. Ahmed | S. Iyer | Dapeng Hao | Omar Moghrabi | O. K. Chi Young | Keyur M Patel | L. Navsaria | R. Steiner | Michael L. Wang | Saira S. Ahmed | C. Flowers | H. Hill | Xingzhi Song | Wendy Y. Chen | Keyur Patel